C
Carolin Kurz
Researcher at Ludwig Maximilian University of Munich
Publications - 27
Citations - 2125
Carolin Kurz is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Medicine & Disease. The author has an hindex of 9, co-authored 13 publications receiving 1341 citations. Previous affiliations of Carolin Kurz include German Center for Neurodegenerative Diseases & Technische Universität München.
Papers
More filters
Journal ArticleDOI
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Günter U. Höglinger,Gesine Respondek,Maria Stamelou,Carolin Kurz,Keith A. Josephs,Anthony E. Lang,Brit Mollenhauer,Ulrich Müller,Christer Nilsson,Jennifer L. Whitwell,Thomas Arzberger,Elisabet Englund,Ellen Gelpi,Armin Giese,David J. Irwin,Wassilios G. Meissner,Wassilios G. Meissner,Alexander Pantelyat,Alex Rajput,John C. van Swieten,Claire Troakes,Angelo Antonini,Kailash P. Bhatia,Yvette Bordelon,Yaroslau Compta,Jean-Christophe Corvol,Carlo Colosimo,Dennis W. Dickson,Richard Dodel,Leslie W. Ferguson,Murray Grossman,Jan Kassubek,Florian Krismer,Johannes Levin,Stefan Lorenzl,Huw R. Morris,Peter J. Nestor,Wolfgang H. Oertel,Werner Poewe,Gil D. Rabinovici,James B. Rowe,Gerard D. Schellenberg,Klaus Seppi,Thilo van Eimeren,Gregor K. Wenning,Adam L. Boxer,Lawrence I. Golbe,Irene Litvan +47 more
TL;DR: Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP have excellent specificity, but their sensitivity is limited for variant PSP syndromes with presentations other than Richardson's syndrome.
Journal ArticleDOI
The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.
Gesine Respondek,Gesine Respondek,Gesine Respondek,Maria Stamelou,Maria Stamelou,Carolin Kurz,Carolin Kurz,Leslie W. Ferguson,Alex Rajput,Wan Zheng Chiu,John C. van Swieten,Claire Troakes,Safa Al Sarraj,Ellen Gelpi,Carles Gaig,Eduardo Tolosa,Wolfgang H. Oertel,Armin Giese,Sigrun Roeber,Thomas Arzberger,Stefan Wagenpfeil,Günter U. Höglinger,Günter U. Höglinger,Günter U. Höglinger +23 more
TL;DR: The phenotypic spectrum of progressive supranuclear palsy may be broader and more variable than previously described in single‐center studies, and too strict clinical criteria defining distinct phenotypes may not reflect this variability.
Journal ArticleDOI
Distribution patterns of tau pathology in progressive supranuclear palsy
Gabor G. Kovacs,Gabor G. Kovacs,Gabor G. Kovacs,Milica Ječmenica Lukić,Milica Ječmenica Lukić,David J. Irwin,Thomas Arzberger,Gesine Respondek,Gesine Respondek,Gesine Respondek,Edward B. Lee,David G. Coughlin,David G. Coughlin,Armin Giese,Murray Grossman,Carolin Kurz,Carolin Kurz,Corey T. McMillan,Ellen Gelpi,Ellen Gelpi,Yaroslau Compta,John C. van Swieten,Laura Donker Laat,Claire Troakes,Safa Al-Sarraj,John L. Robinson,Sigrun Roeber,Sharon X. Xie,Virginia M.-Y. Lee,John Q. Trojanowski,Günter U. Höglinger +30 more
TL;DR: Defining cell-specific stages of tau pathology helps to identify preclinical or early-stage cases for the better understanding of early pathogenic events, has implications for understanding the clinical subtype-specific dynamics of disease-propagation, and informs tau-neuroimaging on distribution patterns.
Journal ArticleDOI
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
Jennifer L. Whitwell,Günter U. Höglinger,Günter U. Höglinger,Angelo Antonini,Yvette Bordelon,Adam L. Boxer,Carlo Colosimo,Thilo van Eimeren,Thilo van Eimeren,Lawrence I. Golbe,Jan Kassubek,Carolin Kurz,Irene Litvan,Alexander Pantelyat,Gil D. Rabinovici,Gesine Respondek,Gesine Respondek,Axel Rominger,James B. Rowe,Maria Stamelou,Keith A. Josephs +20 more
TL;DR: The degree to which structural and molecular neuroimaging metrics fulfill criteria for diagnostic biomarkers of PSP is critically evaluated to discuss the role of biomarkers in the diagnosis of Richardson's syndrome, variant PSP syndromes and autopsy confirmed PSP, and emphasize current shortfalls in the field.
Journal ArticleDOI
Which Ante Mortem Clinical Features Predict Progressive Supranuclear Palsy Pathology
Gesine Respondek,Carolin Kurz,Thomas Arzberger,Yaroslau Compta,Elisabet Englund,Leslie W. Ferguson,Ellen Gelpi,Armin Giese,David J. Irwin,Wassilios G. Meissner,Wassilios G. Meissner,Christer Nilsson,Alexander Pantelyat,Alex Rajput,John C. van Swieten,Claire Troakes,Keith A. Josephs,Anthony E. Lang,Brit Mollenhauer,Ulrich Müller,Jennifer L. Whitwell,Angelo Antonini,Kailash P. Bhatia,Yvette Bordelon,Jean-Christophe Corvol,Carlo Colosimo,Richard Dodel,Murray Grossman,Jan Kassubek,Florian Krismer,Johannes Levin,Stefan Lorenzl,Stefan Lorenzl,Huw R. Morris,Peter J. Nestor,Wolfgang H. Oertel,Gil D. Rabinovici,James B. Rowe,Thilo van Eimeren,Gregor K. Wenning,Adam L. Boxer,Lawrence I. Golbe,Irene Litvan,Maria Stamelou,Günter U. Höglinger +44 more
TL;DR: Progressive supranuclear palsy is a neuropathologically defined disease presenting with a broad spectrum of clinical phenotypes, and there is no known cure for this disease.